Innovation through
efficiency
Our asset-focused portfolio companies, known as ‘CinCos’, are designed to operate within a highly efficient management framework. Each CinCo remains laser-focused on advancing its core therapeutics while leveraging a shared, dedicated team of experts.
One optimized engine
Every CinCo Accelerated
Our integrated hub-and-spoke approach reduces redundancy, accelerates execution, and enables highly capital-efficient drug development. As programs mature, our model provides the flexibility for each CinCo to follow a tailored growth trajectory, giving them the capabilities they need at every stage. The result is a highly scalable engine that drives innovation while maintaining rigorous focus.
Why we’re different
Centralized Execution Engine
A single, dedicated group of cross-functional experts powers the entire portfolio. By centralizing our intellectual capital, we eliminate the operational drag of traditional biotech silos and drive rapid, synchronized execution across every asset.
Frictionless Capital Deployment
Initial financing is provided in part by or entirely through the centralized hub directly to the portfolio. This highly disciplined, milestone-driven financial architecture ensures each therapeutic has the exact capital it needs to accelerate through critical inflection points.
Embedded Clinical Infrastructure
A strategic, deeply integrated partner in Medpace provides immediate, seamless access to global trial execution capabilities and global regulatory know-how, turning typical operational hurdles into a competitive speed advantage.
Let's advance medicine, together
Whether you're a clinical investigator, a potential partner, or considering joining our team - we'd like to hear from you.